Blood Test Predicts Heart Complication Risk in Inherited Condition

A new blood test developed by scientists, including those from Harvard and Oxford, can predict the risk of serious complications in patients with Hypertrophic Cardiomyopathy (HCM), a common inherited heart condition. By measuring NT-Pro-BNP protein levels, the test identifies high-risk individuals for targeted monitoring and life-saving treatments, a global breakthrough in cardiac care.

• New blood test predicts complications for inherited heart condition.
• Targets Hypertrophic Cardiomyopathy (HCM), a common genetic disease.
• Measures NT-Pro-BNP protein levels for early risk detection.
• Identifies patients needing closer monitoring or life-saving treatment.
• Research led by scientists from prestigious universities like Harvard and Oxford.
• Offers potential to transform care for millions of HCM patients worldwide.

Read the full story on Quick Digest.